Wnt/β-catenin pathway activation is not only related to CTNNB1 mutations, but could be induced by inactivating mutations of axin 1 (AXIN1) or APC in 15% and 2% of HCC cases, respectively [26]. This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.